Maladi ya motema

Útá Wikipedia.

Maladi ya motema, mingi mingi eyebani bo makila kozanga kotonda na motema (CHF), esalemaka ntango motema eza kokoka te kotondisa ndenge ekoki mpo na komaintenir circulation ya makila oyo esengeli na posa ya nzoto.[1][2][3] Liloba maladi ya motema oyo ekozongaka mbala na mbala (CHF) to kozanga kotondisa makila na motema (CCF) basaleka yango ndenge moko na oyo ya makila kozanga kotonda na motema.[4] Mingi mpeza bilembo ezalaka pema mokuse, bolembu koleka, mpe makolo kovimba.[5] Pema mokuse mingi mingi ekomaka mabe koleka na bosali physique, ntango ya kolala na se, mpe ekoki kolamusa mutu na butu.[5] Makasi moke mpo na kosala physique mingi mingi ezalaka mpe elembo.[6]

Ntina eye mingi mingi ememaka maladi ya motema eza maladi ya ba artère coronaire na mpe bobebi ya myocarde (crise cardiaque), hypertension artérielle, fibrillation ya muscle ya motema, nkokoso na valvule ya motema, komela masanga koleka ndelo, infection, mpe cardiomyopathie oyo eyebani ntina te.[5][7] Yango ememaka maladi ya motema na bobongoli lolenge to motindo motema esalaka.[5] Eza na lolenge mibale ya maladi ya motema: maladi ya motema kolandana na ventriculaire gauche eye ekosala mabe mpe maladi ya motema oyo eza na fraction ya ejection normale kolandana na makoki ya ventriculaire gauche mpo na kokangama soki eza affecté, to makoki ya motema mpo na komifungola.[5] Monene ya maladi mingi mingi etalemaka na nzela ya botali nkokoso eye mutu azali nayango mpo na kosala physique.[8] Maladi ya motema eza ndenge moko te na bobebi ya myocarde (oyo eteni ya muscle ya motema ekufaka) to arrêt cardiaque (oyo circulation ya makila ekatanaka).[9][10] Bokono misusu oyo ekoki kozala na bilembo neti ya maladi ya motema eza obesité, insuffisance réinale, ba nkokoso ya foie, anémie mpe bokono ya thyroide.[8]

Diagnostic ya maladi esalemaka kolandana na lisitwale ya ndenge bilembo bibandaki komonana mpe examen ya nzoto mpe confirmation na échocardiographie.[11] Komeka makila, électrocardiographie, mpe radiographie ya panzi ekoki kozala ya litomba mpo na koyeba ntina ya maladi.[11] Traitement elandanaka na lolenge na ntina oyo ozalisaki maladi.[11] Epayi ya batu oyo bazali na maladi ya motema ya mua stable kasi ezongaka mbala na mbala, traitement oyo epesamaka mingi mingi eza kobongola ndenge ya kobika neti kotika kobenda likaya,[12] kosala ba exercice physical [13] mpe kobongola eliyeli, na mpe komela nkisi.[12] Epayi ya baye baza na maladi ya motema kolandana na ventriculaire kosala mabe, inhibiteur ya enzyme ya conversion ya angiotensine to blockeur ya récepteur ya angiotensine elongo na bêta-bloquant ezalaka recommandé.[11] Mpo na baye maladi eza makasi, antialdostérone, to hydralazine kobakisa na nitrate, bakoki kosalela yango.[11] Kosalela biye bibakisaka kosuba ezalaka na litomba mpo na kopekisa mayi ekangema na nzoto.[12] Tango mususu, kolandana na ntina, dispositif ya kotiama neti stimulateur ya motema to défibrillateur ya kotiama na motema ekoki kozala recommandé.[11] Na ba cas misusu ya mua kati to ya makasi ekoki kosengela kosala resynchronisation ya motema (CRT)[14] to modulation contractilité ya motema ekoki kozala ya litomba.[15] Stimulateur ya motema oyo etiami na thorax to ntango mususu bakoki korecommander greffe ya motema mpo na baye baza kobela makasi malgré mikano misusu.[12]

Maladi ya motema ezwaka batu ndenge na ndenge, ememaka misolo ebele, mpe ekokaka komema liwa.[7] Na pays développés, pene na 2% ya batu bakolo baza na maladi ya motema mpe baye baza na mibu koleka 65, ezali 6–10%.[7][16] Na mobu eye elendi diagnostic risque ya liwa ezalaka pene na 35% na sima nayango ekitaka na 10% mobu na mobu.[5] Yango eza neti ba risque ya ba lolenge songolo ya cancer.[5] Na Royaume Uni, maladi oyo eza ntina ya 5% ya batu ya ba cas d'urgence oyo balalisamaka na mbeto ya lopitalo.[5] Maladi ya motema eyebana uta kala mpeza wapi Ebers papyrus akolobela yango na mobu 1550 Liboso ya Mbotama ya Kristo.[6]

References[kokoma | kobɔngisa mosólo]

  1. "heart failure" at Dorland's Medical Dictionary
  2. "Heart failure". Health Information. Mayo Clinic. 23 December 2009. http://www.mayoclinic.com/health/heart-failure/DS00061. 
  3. "Definition of Heart failure". Medical Dictionary. MedicineNet. 27 April 2011. http://www.medterms.com/script/main/art.asp?articlekey=3672. 
  4. "Living Well With Chronic Heart Failure". Heart Foundation. p. 18. http://www.heartfoundation.org.au/SiteCollectionDocuments/Living-well-with-chronic-heart-failure.pdf. Retrieved 25 May 2014. 
  5. 5,0 5,1 5,2 5,3 5,4 5,5 5,6 et 5,7 "Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update". National Clinical Guideline Centre: 19–24. Aug 2010. PMID 22741186. 
  6. 6,0 et 6,1 Erreur Lua dans Module:Biblio/Commun à la ligne 29 : attempt to call local 'abr' (a nil value).
  7. 7,0 7,1 et 7,2 McMurray JJ, Pfeffer MA (2005). "Heart failure". Lancet 365 (9474): 1877–89. doi:10.1016/S0140-6736(05)66621-4. PMID 15924986. 
  8. 8,0 et 8,1 "Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update". National Clinical Guideline Centre: 38–70. Aug 2010. PMID 22741186. 
  9. Erreur Lua dans Module:Biblio/Commun à la ligne 29 : attempt to call local 'abr' (a nil value).
  10. Erreur Lua dans Module:Biblio/Commun à la ligne 29 : attempt to call local 'abr' (a nil value).
  11. 11,0 11,1 11,2 11,3 11,4 et 11,5 "Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update". National Clinical Guideline Centre: 34–47. Aug 2010. PMID 22741186. 
  12. 12,0 12,1 12,2 et 12,3 "Chronic Heart Failure: National Clinical Guideline for Diagnosis and Management in Primary and Secondary Care: Partial Update". National Clinical Guideline Centre: 71–153. Aug 2010. PMID 22741186. 
  13. Taylor, RS; Sagar, VA; Davies, EJ; Briscoe, S; Coats, AJ; Dalal, H; Lough, F; Rees, K et al. (Apr 27, 2014). "Exercise-based rehabilitation for heart failure.". The Cochrane database of systematic reviews 4: CD003331. doi:10.1002/14651858.CD003331.pub4. PMID 24771460. 
  14. Tracy, CM (Oct 2, 2012). "2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. [corrected."]. Circulation 126 (14): 1784–1800. doi:10.1161/CIR.0b013e3182618569. PMID 22965336. http://circ.ahajournals.org/content/126/14/1784.full.pdf. Retrieved Apr 29, 2015. 
  15. Kuck, K.-H. (Jan 2014). "New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association". Europace 16 (1): 109–128. doi:10.1093/europace/eut311. PMID 24265466. http://europace.oxfordjournals.org/content/europace/16/1/109.full.pdf. Retrieved Oct 13, 2014. 
  16. "ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)". Eur. Heart J. 29 (19): 2388–442. October 2008. doi:10.1093/eurheartj/ehn309. PMID 18799522. http://eurheartj.oxfordjournals.org/cgi/pmidlookup?view=long&pmid=18799522.